IDXX

IDEXX Laboratories
D

IDXX

Arincen86/100B

IDEXX Laboratories free cash flow 1991–2026

IDEXX Laboratories's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 420.79M USD, up 13.4% on the same quarter a year before. IDEXX Laboratories's free cash flow over the last twelve months was 1.30B USD, up 36.7% on the twelve months before. In fiscal year 2025 it was 1.05B USD, up 32.0% on the year before.

Last updated 7 Nov 2026 · Next report 1 Feb 2027

Free cash flow

Free cash flow · +23.0% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20261.30B+36.74%27.97%1.42B-114.99M16.34
FY202531 Dec 20251.05B+31.99%24.48%1.18B-124.68M13.06
FY202431 Dec 2024798.08M+3.26%20.48%929.00M-130.92M9.59
FY202331 Dec 2023772.88M+96.09%21.11%906.51M-133.63M9.20
FY202231 Dec 2022394.15M-38.03%11.71%542.98M-148.84M4.66
FY202131 Dec 2021636.00M+17.68%19.78%755.55M-119.55M7.35
FY202031 Dec 2020540.44M+77.81%19.97%648.06M-107.63M6.23
FY201931 Dec 2019303.93M+9.66%12.63%459.16M-155.22M3.47
FY201831 Dec 2018277.15M-6.55%12.52%400.08M-122.94M3.13
FY201731 Dec 2017296.57M+9.93%15.06%373.28M-76.70M3.31
FY201631 Dec 2016269.78M+102.17%15.20%334.57M-64.79M2.97
FY201531 Dec 2015133.44M-23.81%8.33%216.36M-82.92M1.42
FY201431 Dec 2014175.15M+4.65%11.79%235.85M-60.70M1.73
FY201331 Dec 2013167.36M+3.80%12.15%246.00M-78.64M1.55
FY201231 Dec 2012161.23M+33.83%12.47%230.28M-69.05M1.44
FY201131 Dec 2011120.48M-13.65%9.89%220.70M-100.22M1.03
FY201031 Dec 2010139.53M+20.42%12.65%178.83M-39.30M1.17
FY200931 Dec 2009115.88M+117.11%11.23%173.72M-57.84M0.95
FY200831 Dec 200853.37M-22.51%5.21%143.34M-89.97M0.43
FY200731 Dec 200768.88M+79.04%7.47%135.12M-66.24M0.53
FY200631 Dec 200638.47M-58.34%5.20%109.83M-71.36M0.29
FY200531 Dec 200592.35M+45.04%14.47%116.55M-24.20M0.68
FY200431 Dec 200463.67M-36.49%11.59%95.38M-31.71M0.44
FY200331 Dec 2003100.26M+13.72%21.06%117.16M-16.90M0.70
FY200231 Dec 200288.17M+204.20%21.36%103.25M-15.09M0.63
FY200131 Dec 200128.98M+127.85%7.51%46.36M-17.38M0.21
FY200031 Dec 200012.72M-68.36%3.46%28.24M-15.52M0.09
FY199931 Dec 199940.20M—11.29%52.60M-12.40M0.25
FY199831 Dec 1998-2.00M—-0.63%46.10M-48.10M-0.01
FY199731 Dec 1997-22.00M—-8.37%13.50M-35.50M-0.15
FY199631 Dec 1996-3.80M—-1.42%8.00M-11.80M-0.02
FY199531 Dec 1995-9.10M-187.50%-4.83%6.80M-15.90M-0.06
FY199431 Dec 199410.40M+96.23%8.23%14.80M-4.40M0.08
FY199331 Dec 19935.30M—5.69%7.40M-2.10M0.04
FY199231 Dec 1992-2.40M—-4.16%-100.00K-2.30M-0.02
FY199131 Dec 1991-5.60M—-18.36%3.80M-9.40M-0.07

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about IDEXX Laboratories's free cash flow

Source: Financial Modeling Prep